Inventor
Laurel Kathryn MCGRANE
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07HSugars25%
C07DHeterocyclic compounds19%
Y02ATechnologies for adaptation to climate change19%
A61KPreparations for medical, dental or toiletry purposes13%
PatentTitleYear
12,552,824C-mannoside compounds useful for the treatment of urinary tract infections202612,351,597Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH202512,297,223Compounds202511,697,665C-mannoside compounds useful for the treatment of urinary tract infections2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to FIMBRION THERAPEUTICS INC (4)· patent assignee history
2023–2026Patents assigned to GLAXOSMITHKLINE IP DEV LTD (4)· patent assignee history
2023–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FIMBRION THERAPEUTICS INC | 4 | 2023–2026 |
| GLAXOSMITHKLINE IP DEV LTD | 4 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2026 |